vasamed Announces Medical Sales Partners as U.S. Distribution Partner for AcQtrac(TM) ICG SYSTEM MSP Trusted Supplier to Cardiology Office Practice MINNEAPOLIS, April 26 /PRNewswire-FirstCall/ -- vasamed (OTC:OPTL) (BULLETIN BOARD: OPTL) a leader in non-invasive, hemodynamic assessment technology and Medical Sales Partners, Inc. announced that they have entered into a contractual agreement under which Medical Sales Partners will provide U.S. distribution for vasamed's AcQtrac(TM) Impedance Cardiography System, a non-invasive cardiac output monitoring system that will also serve as the platform for future versions of vasamed's microvascular assessment and tissue carbon dioxide technologies. "We are extremely pleased to have Medical Sales Partners and their full-service, nationwide team join us in the introduction and distribution of AcQtrac ICG to the cardiology marketplace. Their expertise in cardiovascular sales, service and training is the perfect fit for our plans to make this important cardiovascular test accessible in the physicians' office," said Terry Duesterhoeft, vice president Sales & Marketing of vasamed. "Medical Sales Partners' commitment to customer service and reputation for quality cardiology solutions and services is well-understood in the market place and they have the ability to expand our reach to customers who are seeking to provide a full-range of diagnostic services to their patients." "Our strategic relationship with vasamed and specifically their AcQtrac product roadmap positions MSP strongly to bring the emerging non-invasive hemodynamic assessment modalities to our customers," said Robert Graff, President of Medical Sales Partners. "This partnership brings together two companies both focused on the importance of customer relationships and a corporate vision driven by bringing real clinical value based solutions to our customers." vasamed(TM) designs, licenses, manufactures and distributes products that can be used by your doctor -- right in the office -- to tell him/her whether your heart and blood vessels are healthy. vasamed's products and technology include SensiLase(TM) Microvascular Assessment System to measure Skin Perfusion Pressure (SPP), AcQtrac(TM) Impedance Cardiography (ICG) to monitor heart function and Tissue Carbon Dioxide Technologies, including CapnoProbe(TM), to monitor tissue wellness. For more information about vasamed technology and services and new products, please call (800) 695.2737 or see the company's web site at http://www.vasamed.com/ . Medical Sales Partners provides customer focused solutions to the cardiovascular market through their relationships with GE, Philips, Schiller, Welch Allyn and Heartlabs. Medical Sales Partners sales consultants are dedicated to the cardiology market for hospitals and medical practices in 32 states. For more information on Medical Sales Partners, Inc., please call (702) 838-3939 or visit the company online at http://www.medicalsalespartners.com/ . DATASOURCE: vasamed CONTACT: Wes Peterson, CFO of vasamed, +1-952-944-5857 ext. 542 Web site: http://www.vasamed.com/ http://www.medicalsalespartners.com/

Copyright